AKT1 and hepatocellular carcinoma: Our data show that 3-HAA-upregulated PPP1R15A/PPP1 dephosphorylates/inactivates Akt at Thr308, which could result from the compensatory pathway of Akt activation in sorafenib-resistant HCC cells.